EXCLUSIVE: Ambrosia, the much-maligned startup selling blood transfusions from young donors, is back up and running. read.medium.com/mhryYso
Jesse Karmazin, the CEO and founder of Ambrosia, told @ozm that the company had resumed giving customers transfusions of plasma, the colorless liquid part of the blood, from young donors about a month ago. read.medium.com/mhryYso
Ambrosia’s website claims that transfusions “produce statistically significant improvements” in biomarkers related to Alzheimer’s disease, cancer, and inflammation, and that customers reported “subjective improvements” in memory and sleep. read.medium.com/mhryYso
Experts say there’s no basis for using plasma to slow or reverse aging or age-related diseases, like Karmazin has claimed. Critics have blasted Karmazin’s transfusions as snake oil. read.medium.com/mhryYso
